Insider Shareholders with Direct Ownership of Lumos Pharma, Inc. (LUMO)
This section provides a comprehensive overview of the insiders with direct ownership of Lumos Pharma, Inc. (LUMO). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
LUMOS PHARMA, INC. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Richard J Hawkins
Chief Executive Officer |
15,829 | 760,404 | 753,093 $3.27 Million | 12 |
Apr 01, 2024
Reduced 0.2%
|
|
Carl W. Langren
Chief Financial Officer |
939 | 683 | 11,494 $49,883 | 2 |
Apr 01, 2021
Reduced 5.61%
|
|
Eugene P. Kennedy
Chief Medical Officer |
939 | 0 | 11,423 $49,575 | 1 |
Feb 01, 2021
Added 7.6%
|
|
David B Karpf
Chief Medical Officer |
1,400 | 606 | 8,294 $35,995 | 4 |
Feb 01, 2023
Reduced 0.43%
|
|
Bradley J Powers
General Counsel |
3,569 | 8,124 | 6,307 $27,372 | 12 |
Apr 01, 2024
Reduced 5.14%
|
|
Kevin M. Lalande
Director |
367 | 1,076 | 1,076 $4,669 | 2 |
May 20, 2021
Added 25.43%
|
|
Lori D Lawley
Chief Financial Officer |
7,619 | 14,461 | 0 $0 | 16 |
Dec 12, 2024
Reduced 100.0%
|
|
John C. Mc Kew
Chief Scientific Officer |
26,578 | 42,871 | 0 $0 | 26 |
Dec 12, 2024
Reduced 100.0%
|
|
Joseph S Mc Cracken
Director |
15,012 | 15,721 | 0 $0 | 5 |
Dec 12, 2024
Reduced 100.0%
|
|
Thomas A. Raffin
Director |
1,517 | 9,406 | 0 $0 | 3 |
Dec 12, 2024
Reduced 100.0%
|
|
An Van Es Johansson
Director |
367 | 1,100 | 0 $0 | 2 |
Dec 12, 2024
Reduced 100.0%
|
|
Lota S. Zoth
Director |
367 | 2,187 | 0 $0 | 2 |
Dec 12, 2024
Reduced 100.0%
|
|
Chad Allen Johnson
Director |
367 | 1,076 | 0 $0 | 2 |
Dec 12, 2024
Reduced 100.0%
|
|
Aaron Schuchart
Chief Business Officer |
5,000 | 8,537 | 0 $0 | 9 |
Dec 12, 2024
Reduced 100.0%
|
|
Pisit Duke Pitukcheewanont
Chief Medical Officer |
6,000 | 17,430 | 0 $0 | 4 |
Dec 12, 2024
Reduced 100.0%
|